Search Legislation

Directive 2001/82/EC of the European Parliament and of the CouncilShow full title

Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As adopted by EU)
 Help about advanced features

Advanced Features

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Changes over time for: Article 1

 Help about opening options

Status:

EU Directives are being published on this site to aid cross referencing from UK legislation. After exit day no further amendments will be applied to this version.

Article 1U.K.

For the purposes of this Directive, the following terms shall bear the following meanings:

:

[ F1 ]

[F22. Veterinary medicinal product

:

(a)

any substance or combination of substances presented as having properties for treating or preventing disease in animals; or

(b)

any substance or combination of substances which may be used in or administered to animals with a view either to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action, or to making a medical diagnosis.]

:

[ F1 ]

4. Substance

:

Any matter irrespective of origin which may be:

  • human, e.g.

    human blood and human blood products;

  • animal, e.g.

    micro-organisms, whole animals, parts of organs, animal secretions, toxins, extracts, blood products;

  • vegetable, e.g.

    micro-organisms, plants, parts of plants, vegetable secretions, extracts;

  • chemical, e.g.

    elements, naturally occurring chemical materials and chemical products obtained by chemical change or synthesis.

5. Pre-mix for medicated feedingstuffs

:

Any veterinary medicinal product prepared in advance with a view to the subsequent manufacture of medicated feedingstuffs.

6. Medicated feedingstuffs

:

Any mixture of a veterinary medicinal product or products and feed or feeds which is ready prepared for marketing and intended to be fed to animals without further processing, because of its curative or preventive properties or other properties as a medicinal product covered by point 2.

7. Immunological veterinary medicinal product

:

A veterinary medicinal product administered to animals in order to produce active or passive immunity or to diagnose the state of immunity.

[F28. Homeopathic veterinary medicinal product

:

Any veterinary medicinal product prepared from substances called homeopathic stocks in accordance with a homeopathic manufacturing procedure described by the European Pharmacopoeia or, in the absence thereof, by the pharmacopoeias currently used officially in Member States. A homeopathic veterinary medicinal product may contain a number of principles.

9. Withdrawal period

:

The period necessary between the last administration of the veterinary medicinal product to animals, under normal conditions of use and in accordance with the provisions of this Directive, and the production of foodstuffs from such animals, in order to protect public health by ensuring that such foodstuffs do not contain residues in quantities in excess of the maximum residue limits for active substances laid down pursuant to Regulation (EEC) No 2377/90.

10. Adverse reaction

:

A reaction to a veterinary medicinal product which is harmful and unintended and which occurs at doses normally used in animals for the prophylaxis, diagnosis or treatment of disease or to restore, correct or modify a physiological function.]

11. Human adverse reaction

:

A reaction which is noxious and unintended and which occurs in a human being following exposure to a veterinary medicine.

12. Serious adverse reaction

:

An adverse reaction which results in death, is life-threatening, results in significant disability or incapacity, is a congenital anomaly/birth defect, or which results in permanent or prolonged signs in the animals treated.

13. Unexpected adverse reaction

:

An adverse reaction, the nature, severity or outcome of which is not consistent with the summary of the product characteristics.

14. Periodic safety update reports

:

The periodical reports containing the records referred to in Article 75.

15. Post-marketing surveillance studies

:

Pharmacoepidemiological study or a clinical trial carried out in accordance with the terms of the marketing authorization, conducted with the aim of identifying and investigating a safety hazard relating to an authorized veterinary medicinal product.

16. Off-label use

:

The use of a veterinary medicinal product that is not in accordance with the summary of the product characteristics, including the misuse and serious abuse of the product.

17. Wholesale dealing in veterinary medicinal products

:

Any activity which includes the purchase, sale, import, export, or any other commercial transaction in veterinary medicinal products, whether or not for profit, except for:

  • the supply by a manufacturer of veterinary medicinal products manufactured by himself,

  • retail supplies of veterinary medicinal products by persons entitled to carry out such supplies in accordance with Article 66.

[F317a. Representative of the marketing authorisation holder

:

The person, commonly known as local representative, designated by the marketing authorisation holder to represent him in the Member State concerned.]

[F218. Agency

:

The European Medicines Agency established by Regulation (EC) No 726/2004 (1) .]

[F219. Risks relating to use of the product

:

  • any risk relating to the quality, safety and efficacy of the veterinary medicinal products as regards animal or human health;

  • any risk of undesirable effects on the environment.]

[F320. Risk/benefit balance

:

An evaluation of the positive therapeutic effects of the veterinary medicinal product in relation to the risks as defined above.

21. Veterinary prescription

:

Any prescription for a veterinary medicinal product issued by a professional person qualified to do so in accordance with applicable national law.

22. Name of veterinary medicinal product

:

The name, which may be either an invented name not liable to confusion with the common name, or a common or scientific name accompanied by a trademark or the name of the marketing authorisation holder.

23. Common name

:

The international non-proprietary name recommended by the World Health Organisation, or, if one does not exist, the usual common name.

24. Strength

:

The content of active substances, expressed quantitatively per dosage unit, per unit of volume or weight according to the dosage form.

25. Immediate packaging

:

The container or any other form of packaging that is in direct contact with the medicinal product.

26. Outer packaging

:

The packaging into which is placed the immediate packaging.

27. Labelling

:

Information on the immediate or outer packaging.

28. Package leaflet

:

The leaflet containing information for the user that accompanies the medicinal product.]

Back to top

Options/Help

Print Options

You have chosen to open the Whole Directive

The Whole Directive you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources